Navigation Links
Cynosure Reports Record Revenues for Fourth-Quarter and Full-Year 2012
Date:2/12/2013

WESTFORD, Mass., Feb. 12, 2013 /PRNewswire/ -- Cynosure, Inc. (Nasdaq: CYNO) today reported record revenues for the fourth quarter and full year ended December 31, 2012. Revenues for the fourth quarter increased 25% to $42.7 million from $34.1 million for the same period of 2011, while revenues for the full year of 2012 were up 39% to $153.5 million from $110.6 million for 2011. 

"Our focus on consistently delivering the industry's leading aesthetic workstations and technology innovations enabled Cynosure to generate strong results in 2012," said Michael Davin, Cynosure's President and Chief Executive Officer.  "We believe that we are well positioned to continue our momentum in the year ahead. Demand across North America and our international segments helped to produce record top-line performance for the Company in both the fourth quarter and full year.  At the same time, we continue to achieve additional operating leverage which enhanced our margins and significantly strengthened the bottom line." 

Financial Highlights
Net income for the fourth quarter of 2012 was $4.0 million, or $0.27 per diluted share, compared with $1.1 million, or $0.08 per diluted share, for the fourth quarter of 2011, reflecting increased revenue and improved operating leverage for the 2012 period.  For the full year, net income was $11.0 million, or $0.79 per diluted share, compared with a net loss of $2.9 million, or $0.23 per share, for 2011.

Laser product revenue increased 28% for the fourth quarter of 2012 to $36.5 million from $28.4 million for the same period of 2011, and 45% for the full year to $128.5 million from $88.4 million for 2011.  These increases reflect the U.S. launch of the Company's minimally invasive Cellulaze™ Cellulite Laser Workstation in 2012 and strong demand for its other devices including the Elite™ family
'/>"/>

SOURCE Cynosure, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cynosure Receives FDA Clearance for At-Home Device for the Treatment of Wrinkles
2. Cynosure Announces Upcoming Conference Presentations
3. Cynosure, Inc. Announces Proposed Public Offering of Class A Common Stock
4. Cynosure, Inc. Prices Public Offering of Class A Common Stock
5. Cynosure to Present at Canaccord Genuity Medical Technology & Diagnostics Forum
6. Cynosure to Host Fourth-Quarter 2012 Financial Results Conference Call on February 12
7. Cynosure to Participate in Leerink Swann Global Healthcare Conference 2013
8. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
9. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
10. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
11. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... NEW YORK , June 18, 2013 JDRF ... ) are accelerating the development of new products that combine ... new collaboration announced today. This new, three-year commitment is an ... (T1D). Many patients with T1D not only take ... to be placed in the body for a number of ...
(Date:6/18/2013)... EMERYVILLE, Calif. , June 18, 2013 ... today from a Phase 2/3 clinical trial of ... statistically significant improvement in levodopa-induced dyskinesia (LID) as ... versus placebo in the Unified Dyskinesia Rating Scale ... amantadine intended for once-nightly administration that is being ...
(Date:6/17/2013)... ANGELES , June 17, 2013 Velplex, ... TopProdeals.com , a technology platform that connects buyers and ... into being an industry leader. Why? ... at TopProdeals™ are intimately familiar with the dental industry. ... healthcare community and have diligently worked to negotiate some ...
Breaking Medicine Technology:JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 2JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6TopProdeals.com Rises to Top as Discount Dental Supply Leader 2
... ALLENTOWN, Pa., Jan. 9, 2012    Lehigh Valley Technologies, ... of a recently completed inspection by the U.S. ... 2011, FDA completed an onsite inspection with no ... that there were no negative observations relating to ...
... 9, 2012 Uptake Medical ® today announced ... round. The round was led by Singapore-based Crescent Point ... Venture Partners, WRF Capital, Arboretum Ventures and Affinity Capital, ... will join the Uptake Medical board of directors. Moelis ...
Cached Medicine Technology:Uptake Medical Announces Successful Completion of Series C Financing 2
(Date:6/18/2013)... New York (PRWEB) June 18, 2013 As ... both state and federal court, a new report has revealed ... than 70,000 U.S. Food & Drug Administration (FDA) adverse event ... to NewsChannel5 in Cleveland, Ohio, over 4.700 Mirena users have ... while more than 1,300 have reportedly experienced uterine perforations due ...
(Date:6/18/2013)... York, N.Y., June 18, 2013 -- Lauren Sciences, ... novel V-Smart nanovesicle platform technology, announced today that ... in Drug Delivery with its V-Smart Platform, and ... report by MCD Group. , The ... of Start-ups and Emerging Companies ," features companies ...
(Date:6/18/2013)... Lesbian, Gay, Bisexual and Transgender (LGBT) Pride ... sexual minority youth are still at greater ... according to the Suicide Prevention Resource Center. ... recently published recommendation to improve psychologists, treatment ... improve psychological functioning and reduce depression and ...
(Date:6/18/2013)... 18, 2013): With Medicare penalties on hospitals with ... in 2014, more hospitals are evaluating the most ... A new study appearing in the June issue ... of Surgeons finds that the American College ... NSQIP) led to more accurate data tracking than ...
(Date:6/18/2013)... June 18, 2013 Two weeks ago, eyes ... Philadelphia, Pennsylvania. As reported by CNN on ... building collapse, 13 injured," a building scheduled to be demolished ... shop, and six of those persons succumbed to their injuries. ... the country. , The situation should serve as a reminder ...
Breaking Medicine News(10 mins):Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 3Health News:Sexual minority youth need specialized treatment from therapists 2Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 2Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 3Health News:ACS NSQIP® data is more accurate than administrative data for tracking 30-day hospital readmissions 4Health News:Ensuring The Safety of Pennsylvania Worksites 2Health News:Ensuring The Safety of Pennsylvania Worksites 3
... 28, 2010) Errors in diagnosis place a heavy ... and can be devastating for affected patients. Strengthening ... comprehensive and coordinated primary care could potentially address this ... from Baylor College of Medicine ( www.bcm.edu ) and ...
... Langone Medical Center has begun a clinical trial offering ... This novel, minimally invasive procedure uses a light-activated ... laser fibers in order to destroy prostate cancer cells. ... prostate cancer offers the potential to destroy the cancer ...
... rural hospitals may be quicker and more efficient at ... and are capable of providing a standard of surgical ... provide a comprehensive array of care services, according to ... the University of Louisville Department of Surgery. "The ...
... One of the human body,s most powerful defensive tools, ... toxins and viruses in the bloodstream from reaching the ... of physicians to deliver drugs directly to the brain, ... Rensselaer Polytechnic Institute are endeavoring to solve this problem ...
... Germany, several national health campaigns promote cancer screening by announcing ... is supposed to motivate men to have an examination. But ... journal of the Association for Psychological Science, finds that this ... less likely to choose to get screened. In ...
... Reinberg HealthDay Reporter , MONDAY, July 26 ... cancers, those whose level of prostate-specific antigen (PSA) is ... new study shows. Recent evidence has shown that ... the cancer they die from, but another condition. For ...
Cached Medicine News:Health News:Reform of primary care could reduce diagnostic errors 2Health News:Reform of primary care could reduce diagnostic errors 3Health News:Reform of primary care could reduce diagnostic errors 4Health News:NYU Langone offers vascular-targeted photodynamic therapy for localized prostate cancer 2Health News:Smaller hospitals can provide safe and high-quality surgical care comparable to larger counterparts 2Health News:Smaller hospitals can provide safe and high-quality surgical care comparable to larger counterparts 3Health News:Breaching the blood-brain barrier to create powerful new tools for fighting cancer 2Health News:Breaching the blood-brain barrier to create powerful new tools for fighting cancer 3Health News:Few people are doing it, so why should I? Motivating men to seek cancer screening 2Health News:Most Men With Low-Risk Prostate Cancer Treated Aggressively, Study Shows 2Health News:Most Men With Low-Risk Prostate Cancer Treated Aggressively, Study Shows 3
... the quantitative determination of Erythropoietin (EPO) in human ... diagnostic use, as an aid in the diagnosis ... the administration of recombinant erythropoietin as a biologic ... erythropoietin assay may be used also to aid ...
... The innovative PoleStar N20, exclusively ... for intra-operative MRI. Combining intra-operative ... completely registration-free system, PoleStar N20 is ... tools available today. , , Exceptional ...
... PREMIUM SURGICLIP II™ single use ... Super Interlock™ clips., ,The ... applier has application in many ... occlude vessels and other tubular ...
... Powered LDS™ single use stapler places two ... cartridge jaw and a knife which divides ... , ,The Auto Suture™ Powered LDS™ ... application in abdominal, gynecological, orthopedic, and thoracic ...
Medicine Products: